CX 2019 Presentations

Please note: Some presentations may not be available as permission may not have been given to publish. Sometimes this will include a debate session, during which one speaker has given permission but another speaker has denied it, resulting in the entire session not being uploaded to the website.

CX Vascular Access Masterclass - Wednesday, 17th April
Venue:   Pillar Hall Learning Centre
Time: 08:00 - 17:42
Maintaining and optimising dialysis access
Time: 08:00 - 09:25
Chairing:   Nicholas Inston, Birmingham, United Kingdom
Domenico Valenti, London, United Kingdom
Introduction: Defining the problem
Time: 08:00 - 08:21
Time: 08:00 - 08:08
Why vascular access fails
Speaker:   Nicholas Inston, Birmingham, United Kingdom
Time: 08:08 - 08:16
Central venous catheters - are they bad or are they badly managed?
Speaker:   Haimanot Wasse, President of ASDIN, Chicago, United States
 
Preventing failure
Time: 08:16 - 08:37
Time: 08:16 - 08:24
The use of AVGs instead of CVCs helps to reduce infection rates in patients needing haemodialysis
Speaker:   Ioannis Loukopoulos, London, United Kingdom
Time: 08:24 - 08:32
Graft failure: How much is cannulation to blame?
Speaker:   Shawn Gage, Raleigh, United States
Time: 08:32 - 08:37
Audience participation and discussion
 
Stenosis
Time: 08:37 - 09:25
Time: 08:37 - 08:45
Are all stenoses the same?
Speaker:   Kate Steiner, Stevenage, United Kingdom
Time: 08:45 - 08:53
Preventing stenosis - the RADAR technique
Speaker:   Nirvana Sadaghianloo, Nice, France
Time: 08:53 - 09:01
Preventing stenosis - pharmacological
Speaker:   Paul Gibbs, Portsmouth, United Kingdom
Time: 09:01 - 09:09
Preventing stenosis - mechanical
Speaker:   Nikolaos Karydis, London, United Kingdom
Time: 09:09 - 09:17
Can we prevent stenosis with AVGs?
Speaker:   David Kingsmore, Glasgow, United Kingdom
Time: 09:17 - 09:25
Drug-coated balloons in preventing restenosis in vascular access - the Lutonix AV Global Registry
Speaker:   Panagiotis Kitrou, Patras, Greece
 
AVF stenosis: Case-based presentations
Time: 09:25 - 10:02
Chairing:   Nicholas Inston, Birmingham, United Kingdom
Domenico Valenti, London, United Kingdom
Time: 09:25 - 09:33
Surgical
Speaker:   Karl Illig, Tampa, United States
Time: 09:33 - 09:41
How to investigate and when to treat
Speaker:   Haimanot Wasse, President of ASDIN, Chicago, United States
Time: 09:41 - 09:49
Endovascular
Speaker:   Robert Jones, Birmingham, United Kingdom
Time: 09:49 - 09:57
USS-guided angioplasty
Speaker:   Olivier Pichot, Grenoble, France
Time: 09:57 - 10:02
Audience participation and discussion
 
Coffee and visit to hands-on workshops
Time: 10:00 - 10:30
Can we prevent thrombosis?
Time: 10:30 - 10:44
Chairing:   Nicholas Inston, Birmingham, United Kingdom
Domenico Valenti, London, United Kingdom
Time: 10:30 - 10:38
Role of surveillance
Speaker:   Colin Deane, London, United Kingdom
Time: 10:38 - 10:44
Audience participation and discussion
 
Treating thrombosis in VA: Case-based presentations
Time: 10:44 - 11:14
Time: 10:44 - 10:52
Surgery
Speaker:   Teun Wilmink, Birmingham, United Kingdom
Time: 10:52 - 11:00
Interventional radiology
Speaker:   Robert Jones, Birmingham, United Kingdom
Time: 11:00 - 11:08
When to treat, when to give up
Speaker:   Jason Wilkins, London, United Kingdom
Time: 11:08 - 11:14
Audience participation and discussion
 
Treating vascular thoracic outlet stenosis
Time: 11:14 - 12:30
Time: 11:14 - 11:22
Surgical approaches
Speaker:   Karl Illig, Tampa, United States
Time: 11:22 - 11:30
Radiological
Speaker:   Jeffrey Hull, North Chesterfield, United States
Time: 11:30 - 11:36
Audience participation and discussion
Central stenosis
Time: 11:36 - 11:50
Time: 11:36 - 11:44
Classifying central venous stenosis: When to treat? How to treat?
Speaker:   John Aruny, New Haven, United States
Time: 11:44 - 11:50
Audience participation and discussion
 
Central occlusion
Time: 11:50 - 12:30
Time: 11:50 - 11:58
Recanalisation - inside/out
Speaker:   James Gilbert, Oxford, United Kingdom
Time: 11:58 - 12:06
Recanalisation - outside/in
Speaker:   Timothy Clark, Philadelphia, United States
Time: 12:06 - 12:21
The access algorithm: Can we define an algorithmic approach to vascular access preservation and maintenance?
Faculty:   Nicholas Inston, Birmingham, United Kingdom
Domenico Valenti, London, United Kingdom
Time: 12:21 - 12:30
Audience participation and discussion
 
Lunch and visit to hands-on workshops
Time: 12:30 - 13:30
Lunch Symposium: ESRD Symposium - New technologies and Multi-disciplinary approach: How I treat failing access in my ESRD patients
Time: 12:30 - 13:00
Moderator:   TBA
Time: 12:30 - 12:40
Using WavelinQ for fistula creation
Speaker:   Panagiotis Kitrou, Patras, Greece
Time: 12:40 - 12:50
Patient with a stenosed fistula
Speaker:   Tobias Steinke, Dusseldorf, Germany
Time: 12:50 - 13:00
Patient with dysfunctional access
Speaker:   Ounali Jaffer, Walton on Thames, United Kingdom
 
Innovations in vascular access: Technologies, techniques, and trial updates
Time: 13:30 - 17:42
Chairing:   Nicholas Inston, Birmingham, United Kingdom
Domenico Valenti, London, United Kingdom
Pre-access optimisation
Time: 13:30 - 14:09
Time: 13:30 - 13:38
Fist Assist: Coming to Europe for fistula vein enlargement
Speaker:   Tej Singh, Los Altos Hills, United States
Time: 13:38 - 13:46
Choosing the right vessel prep device to optimise long-term results for dialysis access patients
Speaker:   Matteo Tozzi, Varese, Italy
Time: 13:46 - 13:54
Reducing pain for dialysis access patients: How to improve comfort by using a new balloon technology
Speaker:   Narayan Karunanithy, London, United Kingdom
Time: 13:54 - 14:09
Audience participation and discussion
 
Pharmacology
Time: 14:09 - 14:33
Time: 14:09 - 14:17
Vonapanitase PATENCY-2 trial results in radiocephalic fistulae
Speaker:   Paul Gibbs, Portsmouth, United Kingdom
Time: 14:17 - 14:25
AV fistula outcomes following intra-operative pharmacologic intervention using a perivascularly delivered sirolimus formulation
Speaker:   Sriram Iyer, Cresskill, United States
Time: 14:25 - 14:33
Audience participation and discussion
 
Drug-coated balloons (trial updates)
Time: 14:33 - 16:00
Time: 14:33 - 14:41
Latest update on Lutonix AV Global Registry and IDE trial
Speaker:   Panagiotis Kitrou, Patras, Greece
Time: 14:41 - 14:49
A study of haemodialysis arteriovenous fistulae stenosis treated with Aperto
Speaker:   Qizhuang Jin, Beijing, China
Time: 14:49 - 14:57
IN.PACT AV: Baseline data from the full cohort
Speaker:   Andrew Holden, Auckland, New Zealand
Time: 14:57 - 15:17
DCBs: Is the data on PVD applicable to vascular access?
Moderator:   Nicholas Inston, Birmingham, United Kingdom
Panel:   Panagiotis Kitrou, Patras, Greece
Andrew Holden, Auckland, New Zealand
Kate Steiner, Stevenage, United Kingdom
Robert Jones, Birmingham, United Kingdom
Time: 15:17 - 15:30
Audience participation and discussion
Tea and visit to hands-on workshops
Time: 15:30 - 16:00
 
AV fistulae
Time: 16:00 - 16:28
Chairing:   Nicholas Inston, Birmingham, United Kingdom
Domenico Valenti, London, United Kingdom
Time: 16:00 - 16:08
Vascular access - using patient reporting to guide decision making
Speaker:   Melanie Field, Birmingham, United Kingdom
Time: 16:08 - 16:16
AV fistulae - VasQ device
Speaker:   Nikolaos Karydis, London, United Kingdom
Time: 16:16 - 16:28
Audience participation and discussion
 
Grafts and stent grafts
Time: 16:28 - 17:42
Time: 16:28 - 16:36
Avoiding central venous catheters: How early cannulation grafts decrease complications and improve patient care
Speaker:   Sapan Desai, Arlington Heights, United States
Time: 16:36 - 16:44
Thrombotic failures: Making the case for use of stent grafts to treat AV access circuits
Speaker:   John Aruny, New Haven, United States
Time: 16:44 - 16:52
Viabahn stent for haemodialysis shunt: Efficacy, long segment recanalisation and prognostic factors for reintervention
Speaker:   Matteo Barattini, La Spezia, Italy
Time: 16:52 - 17:00
Results of stent graft placement to treat cephalic arch stenosis in hemodialysis patients with dysfunctional brachiocephalic arteriovenous fistulae
Speaker:   Robert Jones, Birmingham, United Kingdom
Time: 17:00 - 17:12
Audience, participation and discussion
Time: 17:12 - 17:32
CX Debate: Interventional nephrology improves dialysis patient outcomes

For the motion
Time: 17:12 - 17:22
Haimanot Wasse, President of ASDIN, Chicago, United States
CLICK HERE TO VIEW VIDEO

Against the motion
Time: 17:22 - 17:32
Paul Gibbs, Portsmouth, United Kingdom
CLICK HERE TO VIEW VIDEO

Time: 17:32 - 17:42
Audience participation, discussion and polling
 
Summary and close of day 1
Time: 17:42 - 17:50